Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000277 · ClinicalTrials.gov registry record · Phase 2

Mazindol for Cocaine Abuse - 2

A Phase 2 study, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase

NCT00000277: Completed Phase 2 study, sponsored by Yale University.

NCT00000277 is a Phase 2 study that has completed, run by Yale University. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000277, a Phase 2 study, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase

Study Summary

The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

Interventions

  • DRUG Mazindol

Trial Details

FieldValue
Start Date 1994-09
Est. Completion 1999-08
Phase Phase 2
Yale University

1,492 total trials

What the finished NCT00000277 record still lists

NCT00000277 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which Mazindol is the first listed.

NCT00000277 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00000277 about?

NCT00000277 is a clinical study titled "Mazindol for Cocaine Abuse - 2". The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

What is the current status of trial NCT00000277?

This trial is currently completed. It is a Phase 2 study. The study started on 1994-09. Estimated completion is 1999-08.

What interventions are being tested in trial NCT00000277?

The interventions under investigation include: Mazindol (DRUG).

Who is sponsoring clinical trial NCT00000277?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000277, the US trial registry maintained by the National Library of Medicine. NCT00000277 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.